← Back to Clinical Trials
Recruiting NCT07351916

NCT07351916 Remission in Adults With Mild-to-moderate Asthma in Thailand

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07351916
Status Recruiting
Phase
Sponsor Thammasat University
Condition Asthma
Study Type OBSERVATIONAL
Enrollment 289 participants
Start Date 2026-02-01
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Global Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnairesSpirometryFractional exhaled nitric oxide (FeNO) test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 289 participants in total. It began in 2026-02-01 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.

Eligibility Criteria

Inclusion Criteria: * mild-to-moderate asthma * age 18 years or older Exclusion Criteria: * inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test

Contact & Investigator

Central Contact

Narongkorn Saiphoklang, MD

✉ M_narongkorn@hotmail.com

📞 +6629269794

Principal Investigator

Narongkorn Saiphoklang, MD

PRINCIPAL INVESTIGATOR

Thammasat University Faculty of Medicine

Frequently Asked Questions

Who can join the NCT07351916 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07351916 currently recruiting?

Yes, NCT07351916 is actively recruiting participants. Contact the research team at M_narongkorn@hotmail.com for enrollment information.

Where is the NCT07351916 trial being conducted?

This trial is being conducted at Pathum Thani, Thailand, Pathum Thani, Thailand.

Who is sponsoring the NCT07351916 clinical trial?

NCT07351916 is sponsored by Thammasat University. The principal investigator is Narongkorn Saiphoklang, MD at Thammasat University Faculty of Medicine. The trial plans to enroll 289 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology